from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1742/-

LFCtreatmentdescriptionclass of inhibitor

-0.516

Amikacinug/mL Amikacintranslation

-0.365

Cap5-10ug/mL Capreomycintranslation

1.965

Rox10-50 ug/mL Roxithromycintranslation

-0.342

SM2-5 ug/mL Streptomycintranslation

-0.085

Tet5-10 ug/mL Tetracyclinetranslation

-0.221

Rif0.2-5ug/mL Rifampicintranscription

-1.180

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.379

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.044

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.274

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.302

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.447

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.040

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.729

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.597

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.873

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.019

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.629

Nigericin50 uM Nigericinrespiration

-0.626

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-1.224

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.801

menadione6-10 ug/mL Menadionerespiration

0.038

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.576

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.066

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.195

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.048

NRP_1Non-replicating persistence stage 1dosRassociated

-0.077

Amp0.2mg/mL AmpicillincellWall

-0.246

Cephalexin20-100 ug/mL CephalexincellWall

0.282

Cerulenin0.32-5 ug/mL CerulenincellWall

0.347

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.256

EMB10-20 ug/mL EthambutolcellWall

-0.292

Eta12-40 ug/mL EthionamidecellWall

-0.403

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.301

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.360

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.333

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.548

BZA0.12 mg/mL BenzamidearomaticAmides

-0.396

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.197

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.182

H2O24 mM hydrogen peroxideDNAdamaging

-0.488

Levo10 ug/mL LevofloxacinDNAdamaging

-0.014

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.060

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.462

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.090

UVUV-irradiationDNAdamaging

0.435

ARP41-4 ug/mL Antitubercular compound ARP4?

0.270

Antimycin12.5-50 ug/mL Antimycin A?

-1.339

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.634

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.939

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.733

PA8240.2-2 ug/mL PA-824?

0.417

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.134

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.282

Verapamil50 uM Verapamil?

-1.125

mercaptoethanol2 mM 2-Mercaptoethanol?

0.805

methoxatin10-20 ug/mL Methoxatin?